Abstract
Recommendations for treatment of hepatitis C in 2026 from the Polish Group of Experts for HCV
Department of Infectious Diseases and Hepatology, USK-1, Medical University of Lublin, Poland
Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Poland
Department of Infectious Diseases and Hepatology, Medical University of Silesia in Katowice, Poland
Department of General, Transplantation and Liver Surgery, Medical University of Warsaw, Poland
Department of Infectious Diseases and Hepatology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland
Department of Infectious Diseases and Hepatology, Medical University of Lodz, Poland
Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Poland
Department of Infectious Diseases and Allergology, Jan Kochanowski University of Kielce, Poland
Clin Exp HEPATOL 2026; 12, 3: 191–199
The recommendations outline the principles of diagnosis and treatment of hepatitis C virus (HCV) infection in accordance with the latest evidence. The primary goal of HCV treatment is to eliminate the virus from the body, which in turn can halt the progression or promote regression of liver lesions. The current version of the recommendations prioritizes pangenotypic regimens and includes guidelines for special patient populations, such as children, patients with cirrhosis, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection, patients with renal failure, liver failure, and those who do not respond to previous therapies, as well as patients in the peri-transplant period.
Keywords
HCV, recommendations, therapy, viral hepatitis, liver
Coverage in
Integrated with
